Article Details

CD47 blockade continues on its bumpy journey - Evaluate Pharma

Retrieved on: 2022-07-21 20:01:20

Tags for this article:

Click the tags to see associated articles and topics

CD47 blockade continues on its bumpy journey - Evaluate Pharma. View article details on hiswai:

Excerpt

AK117, Akeso Biopharma, Anti-CD47 MAb ; HX009, Waterstone Hanxbio, Anti-CD47xPD-1 bispecific MAb ; Phase 1/2.

Article found on: www.evaluate.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up